Adam Studebaker

1.1k total citations
21 papers, 885 citations indexed

About

Adam Studebaker is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Adam Studebaker has authored 21 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Oncology. Recurrent topics in Adam Studebaker's work include Virus-based gene therapy research (9 papers), interferon and immune responses (6 papers) and Virology and Viral Diseases (3 papers). Adam Studebaker is often cited by papers focused on Virus-based gene therapy research (9 papers), interferon and immune responses (6 papers) and Virology and Viral Diseases (3 papers). Adam Studebaker collaborates with scholars based in United States, Italy and Germany. Adam Studebaker's co-authors include Brett M. Hall, A. Kate Sasser, Amy Axel, Christopher R. Pierson, Brian Hutzen, Nicholas J. Sullivan, Stephen J. Russell, Pasquale Sansone, Frank C. Marini and Michael W.Y. Chan and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Adam Studebaker

21 papers receiving 873 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adam Studebaker United States 13 444 396 195 149 146 21 885
Tiangui Huang United States 12 225 0.5× 324 0.8× 209 1.1× 83 0.6× 133 0.9× 19 790
Chelsea Bolyard United States 15 338 0.8× 303 0.8× 252 1.3× 58 0.4× 286 2.0× 24 782
Luisa Albano Italy 11 438 1.0× 780 2.0× 341 1.7× 84 0.6× 108 0.7× 22 1.1k
Caroline Geisen Germany 14 351 0.8× 535 1.4× 216 1.1× 58 0.4× 170 1.2× 24 980
Mercedes Gallardo Spain 13 500 1.1× 1.1k 2.7× 253 1.3× 85 0.6× 248 1.7× 14 1.7k
Roland Geisberger Austria 18 417 0.9× 388 1.0× 73 0.4× 184 1.2× 526 3.6× 49 1.1k
Valérie Lang Spain 17 412 0.9× 812 2.1× 75 0.4× 128 0.9× 308 2.1× 23 1.2k
Jenkins United Kingdom 13 414 0.9× 449 1.1× 109 0.6× 106 0.7× 41 0.3× 24 910
Ronglin Xie United States 18 264 0.6× 754 1.9× 101 0.5× 56 0.4× 108 0.7× 31 1.0k
Frédéric Barabé Canada 20 286 0.6× 732 1.8× 78 0.4× 116 0.8× 348 2.4× 38 1.3k

Countries citing papers authored by Adam Studebaker

Since Specialization
Citations

This map shows the geographic impact of Adam Studebaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Studebaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Studebaker more than expected).

Fields of papers citing papers by Adam Studebaker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam Studebaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Studebaker. The network helps show where Adam Studebaker may publish in the future.

Co-authorship network of co-authors of Adam Studebaker

This figure shows the co-authorship network connecting the top 25 collaborators of Adam Studebaker. A scholar is included among the top collaborators of Adam Studebaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam Studebaker. Adam Studebaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Studebaker, Adam, L.T. Smith, Chun‐Yu Chen, et al.. (2023). Oncolytic virus-driven immune remodeling revealed in mouse medulloblastomas at single cell resolution. Molecular Therapy — Oncolytics. 30. 39–55. 8 indexed citations
2.
Li, Fuyang, Adam Studebaker, Qianqian Liu, et al.. (2022). Regulation of TORC1 by MAPK Signaling Determines Sensitivity and Acquired Resistance to Trametinib in Pediatric BRAFV600E Brain Tumor Models. Clinical Cancer Research. 28(17). 3836–3849. 6 indexed citations
3.
Cam, Maren, Manish Charan, Alessandra M. Welker, et al.. (2019). ΔNp73/ETS2 complex drives glioblastoma pathogenesis— targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma. Neuro-Oncology. 22(3). 345–356. 27 indexed citations
4.
Studebaker, Adam, Brian Hutzen, Christopher R. Pierson, et al.. (2017). Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors. Molecular Therapy — Oncolytics. 6. 22–30. 36 indexed citations
5.
Studebaker, Adam, et al.. (2015). Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors. Neuro-Oncology. 17(12). 1568–1577. 23 indexed citations
6.
7.
Studebaker, Adam, Corey Raffel, & Brian Hutzen. (2015). Advances in the design and development of oncolytic measles viruses. PubMed. 4. 109–109. 8 indexed citations
8.
Hutzen, Brian, Hemant K. Bid, Peter J. Houghton, et al.. (2014). Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin. BMC Cancer. 14(1). 206–206. 32 indexed citations
9.
Studebaker, Adam, Brian Hutzen, Christopher R. Pierson, et al.. (2012). Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma. Neuro-Oncology. 14(4). 459–470. 37 indexed citations
10.
Hutzen, Brian, Christopher R. Pierson, Stephen J. Russell, et al.. (2012). Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine. BMC Cancer. 12(1). 508–508. 33 indexed citations
11.
Studebaker, Adam, et al.. (2010). Treatment of medulloblastoma with a modified measles virus. Neuro-Oncology. 12(10). 1034–1042. 57 indexed citations
12.
Sobo, Matthew, Sarah Ball, Brian Hutzen, et al.. (2009). MI-63: A novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53. British Journal of Cancer. 101(5). 774–781. 64 indexed citations
13.
Studebaker, Adam, Gianluca Storci, Jillian L. Werbeck, et al.. (2008). Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner. Cancer Research. 68(21). 9087–9095. 198 indexed citations
14.
Sasser, A. Kate, Bethany L. Mundy-Bosse, Kristen M. Smith, et al.. (2007). Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Letters. 254(2). 255–264. 102 indexed citations
15.
Sasser, A. Kate, et al.. (2007). Interleukin‐6 is a potent growth factor for ER‐α‐positive human breast cancer. The FASEB Journal. 21(13). 3763–3770. 187 indexed citations
16.
Studebaker, Adam, Maria E. Ariza, & Marshall V. Williams. (2005). Depletion of uracil-DNA glycosylase activity is associated with decreased cell proliferation. Biochemical and Biophysical Research Communications. 334(2). 509–515. 10 indexed citations
17.
Williams, Marshall V. & Adam Studebaker. (2004). Down–Regulation of Human Deoxyuridine Triphosphate Nucleotidohydrolase (dUTPase) Using Small Interfering RNA (siRNA). Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1467–1470. 2 indexed citations
18.
Studebaker, Adam, et al.. (2004). Modulation of human dUTPase using small interfering RNA. Biochemical and Biophysical Research Communications. 327(1). 306–310. 17 indexed citations
19.
Studebaker, Adam, Maria E. Ariza, Ganesaratnam K. Balendiran, & Marshall V. Williams. (2004). Novel Approaches for Modulating dUTPase and Uracil-DNA Glycosylase: Potential Uses for Cancer and Viral Chemotherapy. 1(1). 1–13. 2 indexed citations
20.
Studebaker, Adam, Ganesaratnam K. Balendiran, & Marshall V. Williams. (2001). The Herpesvirus Encoded dUTPase as a Potential Chemotherapeutic Target. Current Protein and Peptide Science. 2(4). 371–379. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tiangui Huang Breakdown of academic impact, for papers by Chelsea Bolyard Breakdown of academic impact, for papers by Luisa Albano Breakdown of academic impact, for papers by Caroline Geisen Breakdown of academic impact, for papers by Mercedes Gallardo Breakdown of academic impact, for papers by Roland Geisberger Breakdown of academic impact, for papers by Valérie Lang Breakdown of academic impact, for papers by Jenkins Breakdown of academic impact, for papers by Ronglin Xie Breakdown of academic impact, for papers by Frédéric Barabé
Rankless by CCL
2026